2 results match your criteria: "Millennium Institute on Immunology and Immunotherapy. Laboratory of Integrative Biology (LIBi)[Affiliation]"
Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022.
Front Oncol
November 2024
Millennium Institute on Immunology and Immunotherapy. Laboratory of Integrative Biology (LIBi), Centro de Excelencia en Medicina Traslacional (CEMT), Scientific and Technological Bioresource Nucleus (BIOREN), Universidad de La Frontera, Temuco, Chile.
Background: Late diagnosis and patient relapse, mainly due to chemoresistance, are the key reasons for the high mortality rate of ovarian cancer patients. Hence, the search for biomarkers of high predictive value within the phenomenon of chemoresistance is vital. This study performs a bibliometric analysis of the scientific literature concerning biomarkers of drug resistance in ovarian cancer, considering the period from 2017 to 2022.
View Article and Find Full Text PDFIsolation and characterization of A14.2, a strain with immunomodulating activity on .
Saudi J Biol Sci
April 2023
Department of Microbiology, Faculty of Biological Sciences, Universidad de Concepción, Víctor Lamas 1290, Concepción 4030000, Chile.
Considering the economic and environmental role played by bees and their present threats it is necessary to develop food supplements favoring their health. The aim of this work was to isolate and characterize an immunomodulating probiotic capable to improve the health of honeybee colonies. For this purpose, bacterial strains were isolated from bees (N = 180) obtained at three apiaries.
View Article and Find Full Text PDF